Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.23B |
| 2 |
Abbott
ABT
|
+$1.36B |
| 3 |
Honeywell
HON
|
+$959M |
| 4 |
EOG Resources
EOG
|
+$769M |
| 5 |
Emerson Electric
EMR
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.84B |
| 2 |
TJX Companies
TJX
|
+$1.53B |
| 3 |
Baxter International
BAX
|
+$1.23B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Apple
AAPL
|
+$935M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.3% |
| 2 | Technology | 15.48% |
| 3 | Financials | 14.45% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Celestica
CLS
$41.7B
| $3.79M | ﹤0.01% |
336,696
-11,570
| -3% | -$122K |
|
1302
Bread Financial
BFH
$4.54B
| $3.79M | ﹤0.01% |
100,740
+92,149
| +1,073% | +$3.33M |
|
1303
OP Bancorp
OPBK
$235M
| $3.78M | ﹤0.01% |
338,494
-99,700
| -23% | -$1.14M |
|
1304
IES Holdings
IESC
$15.6B
| $3.77M | ﹤0.01% |
106,100
+43,200
| +69% | +$1.4M |
|
1305
Kiniksa Pharmaceuticals
KNSA
$6.09B
| $3.73M | ﹤0.01% |
248,963
-18,803
| -7% | -$274K |
|
1306
Warner Bros
WBD
$65.1B
| $3.72M | ﹤0.01% |
392,283
-60,765
| -13% | -$686K |
|
1307
Brookfield Renewable
BEPC
$6.18B
| $3.69M | ﹤0.01% |
+134,331
| New | +$4.15M |
|
|
ZINGU
1308
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
| $3.69M | ﹤0.01% |
368,161
| – | – |
|
1309
Genco Shipping & Trading
GNK
$1.11B
| $3.69M | ﹤0.01% |
240,287
+196,800
| +453% | +$2.85M |
|
1310
KB Financial Group
KB
$42.4B
| $3.67M | ﹤0.01% |
95,044
-35,711
| -27% | -$1.29M |
|
|
RXDX
1311
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.67M | ﹤0.01% |
33,394
+14,704
| +79% | +$953K |
|
1312
State Street SPDR S&P Regional Banking ETF
KRE
$4.71B
| $3.64M | ﹤0.01% |
61,983
+30,236
| +95% | +$1.86M |
|
1313
Occidental Petroleum
OXY
$53.5B
| $3.6M | ﹤0.01% |
57,185
+35,776
| +167% | +$2.44M |
|
1314
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.49B
| $3.59M | ﹤0.01% |
26,411
+9,149
| +53% | +$1.33M |
|
1315
Midland States Bancorp
MSBI
$711M
| $3.58M | ﹤0.01% |
134,512
-5,262
| -4% | -$140K |
|
1316
Worthington Enterprises
WOR
$2.87B
| $3.58M | ﹤0.01% |
116,808
+134
| +0.1% | +$4.15K |
|
1317
XPEL
XPEL
$1.39B
| $3.55M | ﹤0.01% |
59,157
+13,084
| +28% | +$836K |
|
1318
Argan
AGX
$8.44B
| $3.55M | ﹤0.01% |
+96,200
| New | +$3.38M |
|
1319
GXO Logistics
GXO
$5.48B
| $3.53M | ﹤0.01% |
+82,774
| New | +$3.32M |
|
1320
Viridian Therapeutics
VRDN
$2.33B
| $3.52M | ﹤0.01% |
+120,503
| New | +$2.78M |
|
1321
US Bancorp
USB
$100B
| $3.52M | ﹤0.01% |
80,638
+7,443
| +10% | +$319K |
|
|
AEPPZ
1322
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $3.47M | ﹤0.01% |
66,856
-3,000
| -4% | -$153K |
|
1323
Virtu Financial
VIRT
$5.16B
| $3.44M | ﹤0.01% |
168,484
+30,849
| +22% | +$670K |
|
1324
Peoples Bancorp of North Carolina
PEBK
$231M
| $3.43M | ﹤0.01% |
105,419
| – | – |
|
1325
Destination XL Group
DXLG
$30.7M
| $3.43M | ﹤0.01% |
+508,100
| New | +$3.26M |
|
Similar funds
Wellington Management Group's Q4 2022 Portfolio in Review
As of Q4 2022, Wellington Management Group held 2,204 positions worth $499B, up 6.2% from $469B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wellington Management Group withdrew a net $16.1B in Q4 2022, closing 226 positions and reducing 867 holdings. Its most notable exit was Abiomed Inc, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Wellington Management Group opened a new position in U-Haul Holding Co Series N worth $209M.
- Wellington Management Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 3,802,513 shares worth $209M.
- Wellington Management Group added most to Merck in Q4 2022, an estimated $2.23B increase.
- Wellington Management Group's biggest Q4 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.84B.
- Wellington Management Group fully exited Abiomed Inc in Q4 2022, selling an estimated $357M.
- Wellington Management Group's ten largest holdings make up 17% of its $499B portfolio in Q4 2022.
- Wellington Management Group opened 185 new positions and closed 226 in Q4 2022.
- Wellington Management Group's portfolio value rose 6.2% quarter-over-quarter to $499B.
Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.